The growth inhibitory role and potential clinical value of Macrophage Inflammatory Protein 1 alpha in myeloid leukaemias

P. J. Owen-Lynch, L. G. Czaplewski, M. G. Hunter, A. D. Whetton

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The control of primitive haemopoietic progenitor cell proliferation in vitro can be achieved with combinations of growth stimulatory cytokines. Acting in apparent opposition to these growth stimulators are growth inhibitory substances, including prostaglandins, cytokines and chemokines which bind to specific cognate cell surface receptors and promote signal transduction events that interfere with cellular proliferation. Within the bone marrow microenvironment, significant quantities of both growth inhibitors and growth promoters can be detected. The ratio of their concentrations within microenvironmental niches of the marrow may regulate primitive blood cell production. The potential exists, therefore, for the disregulation of haemopoiesis via the disruption of the balance between positive and negative regulators of haemopoietic progenitor proliferation. In one particular disease, chronic myeloid leukaemia (CML), there is a lack of response of leukaemic cells to the chemokine growth inhibitor, Macrophage Inflammatory Protein-1alpha (MIP-1alpha). The role of MIP-1alpha in regulation of haemopoiesis, the response of CML progenitor cells and other myeloid leukaemic cells to this chemokine, and the reasons for lack of response to MIP-1alpha in leukaemic cells are reviewed.

LanguageEnglish
Pages41-53
Number of pages13
JournalLeukemia and Lymphoma
Volume30
Issue number1-2
DOIs
Publication statusPublished - 1 Jan 1998
Externally publishedYes

Fingerprint

Chemokine CCL3
Macrophage Inflammatory Proteins
Myeloid Leukemia
Chemokines
Growth Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Growth
Bone Marrow
Cell Proliferation
Growth Substances
Cytokines
Myeloid Progenitor Cells
Cell Surface Receptors
Myeloid Cells
Prostaglandins
Signal Transduction
Blood Cells
Stem Cells

Cite this

@article{cf75f12cb0b0496b94f16355d27344fc,
title = "The growth inhibitory role and potential clinical value of Macrophage Inflammatory Protein 1 alpha in myeloid leukaemias",
abstract = "The control of primitive haemopoietic progenitor cell proliferation in vitro can be achieved with combinations of growth stimulatory cytokines. Acting in apparent opposition to these growth stimulators are growth inhibitory substances, including prostaglandins, cytokines and chemokines which bind to specific cognate cell surface receptors and promote signal transduction events that interfere with cellular proliferation. Within the bone marrow microenvironment, significant quantities of both growth inhibitors and growth promoters can be detected. The ratio of their concentrations within microenvironmental niches of the marrow may regulate primitive blood cell production. The potential exists, therefore, for the disregulation of haemopoiesis via the disruption of the balance between positive and negative regulators of haemopoietic progenitor proliferation. In one particular disease, chronic myeloid leukaemia (CML), there is a lack of response of leukaemic cells to the chemokine growth inhibitor, Macrophage Inflammatory Protein-1alpha (MIP-1alpha). The role of MIP-1alpha in regulation of haemopoiesis, the response of CML progenitor cells and other myeloid leukaemic cells to this chemokine, and the reasons for lack of response to MIP-1alpha in leukaemic cells are reviewed.",
keywords = "CML, Growth inhibition, Macrophage inflammatory protein-1alpha, MIP-1alpha, Myeloid leukaemias",
author = "Owen-Lynch, {P. J.} and Czaplewski, {L. G.} and Hunter, {M. G.} and Whetton, {A. D.}",
year = "1998",
month = "1",
day = "1",
doi = "10.3109/10428199809050928",
language = "English",
volume = "30",
pages = "41--53",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1-2",

}

The growth inhibitory role and potential clinical value of Macrophage Inflammatory Protein 1 alpha in myeloid leukaemias. / Owen-Lynch, P. J.; Czaplewski, L. G.; Hunter, M. G.; Whetton, A. D.

In: Leukemia and Lymphoma, Vol. 30, No. 1-2, 01.01.1998, p. 41-53.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The growth inhibitory role and potential clinical value of Macrophage Inflammatory Protein 1 alpha in myeloid leukaemias

AU - Owen-Lynch, P. J.

AU - Czaplewski, L. G.

AU - Hunter, M. G.

AU - Whetton, A. D.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The control of primitive haemopoietic progenitor cell proliferation in vitro can be achieved with combinations of growth stimulatory cytokines. Acting in apparent opposition to these growth stimulators are growth inhibitory substances, including prostaglandins, cytokines and chemokines which bind to specific cognate cell surface receptors and promote signal transduction events that interfere with cellular proliferation. Within the bone marrow microenvironment, significant quantities of both growth inhibitors and growth promoters can be detected. The ratio of their concentrations within microenvironmental niches of the marrow may regulate primitive blood cell production. The potential exists, therefore, for the disregulation of haemopoiesis via the disruption of the balance between positive and negative regulators of haemopoietic progenitor proliferation. In one particular disease, chronic myeloid leukaemia (CML), there is a lack of response of leukaemic cells to the chemokine growth inhibitor, Macrophage Inflammatory Protein-1alpha (MIP-1alpha). The role of MIP-1alpha in regulation of haemopoiesis, the response of CML progenitor cells and other myeloid leukaemic cells to this chemokine, and the reasons for lack of response to MIP-1alpha in leukaemic cells are reviewed.

AB - The control of primitive haemopoietic progenitor cell proliferation in vitro can be achieved with combinations of growth stimulatory cytokines. Acting in apparent opposition to these growth stimulators are growth inhibitory substances, including prostaglandins, cytokines and chemokines which bind to specific cognate cell surface receptors and promote signal transduction events that interfere with cellular proliferation. Within the bone marrow microenvironment, significant quantities of both growth inhibitors and growth promoters can be detected. The ratio of their concentrations within microenvironmental niches of the marrow may regulate primitive blood cell production. The potential exists, therefore, for the disregulation of haemopoiesis via the disruption of the balance between positive and negative regulators of haemopoietic progenitor proliferation. In one particular disease, chronic myeloid leukaemia (CML), there is a lack of response of leukaemic cells to the chemokine growth inhibitor, Macrophage Inflammatory Protein-1alpha (MIP-1alpha). The role of MIP-1alpha in regulation of haemopoiesis, the response of CML progenitor cells and other myeloid leukaemic cells to this chemokine, and the reasons for lack of response to MIP-1alpha in leukaemic cells are reviewed.

KW - CML

KW - Growth inhibition

KW - Macrophage inflammatory protein-1alpha

KW - MIP-1alpha

KW - Myeloid leukaemias

UR - http://www.scopus.com/inward/record.url?scp=0031867876&partnerID=8YFLogxK

U2 - 10.3109/10428199809050928

DO - 10.3109/10428199809050928

M3 - Review article

VL - 30

SP - 41

EP - 53

JO - Leukemia and Lymphoma

T2 - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1-2

ER -